Symbol not found

:MYOV   00:00AM GMT
0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)NA
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$244.82 Million
Adjusted EPS$0.56
See more estimates
10-Day MAN/A
50-Day MAN/A
200-Day MAN/A
See more pivots

Myovant Sciences Ltd Stock, :MYOV

11-12 St. James�s Square, Suite 1, 3rd Floor, London, Greater London SW1Y 4LB
Phone: +44.207.400.3351
Number of Employees: 579


Myovant Sciences is a biotech company that develops new treatments for infertility in women and prostate cancer in men. The company's product capabilities and help continue to deliver innovative therapies addressing unmet patient needs in prostate cancer and women�s health. Myovant Sciences was established in 2016 and is based in Brisbane, California.